JL

Jakob Lindberg

CEO

Oncopeptides AB

Stockholm, Stockholm County


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Oncopeptides AB
Industry
pharmaceuticals
Employees
87.0
Seniority
C suite
Annual Revenue
3858000.0

Technologies

CSC Corporate Domains Outlook Microsoft Office 365 CloudFlare Hosting Google Maps Google Font API Vimeo Mobile Friendly Google Maps (Non Paid Users) Google Tag Manager Google Analytics Basis

Keywords

multiple myeloma plasma cell myeloma orphan drug relapsed relapsedrefractory multiple myeloma antiangiogenic cytotoxicity alkylation peptidase targeting efficacy studies oncology peptide conjugated alkylator phase 1 phase 3 melflufen rrmm peptidedrug conjugate melphalan flufenamide phase 2 emd pharmaceutical manufacturing biotech targeted therapies pepaxti clinical trials cancer research innovation peptide drug conjugates investor relations regulatory approval market access sustainability real-world evidence medical affairs pharmacovigilance clinical program drug development research & development access programs european medicines agency patient safety market commercialization cancer treatment chemotherapy drug formulation biopharmaceutical pharmaceutical industry uptake rate clinical efficacy medical communications clinical outcomes investor presentations oncology conferences patient population disease progression therapeutic indication medicinal products pricing agreements health economics future prospects drug approval process compassionate use pharmaceutical market treatment landscape innovative treatments oncology drugs therapeutic areas healthcare stakeholders eap programs biotechnology hematological cancers peptide drug conjugate pdc platform innovative drug development patient access programs drug commercialization european markets healthcare professionals oncology specialists patient quality of life unmet medical needs spike platform therapeutic focus market expansion clinical development entrepreneurial spirit science-driven sustainable practices moderate esg risk patient outcomes real-world data clinical studies competitive landscape emerging markets geographical reach oncology therapeutics drug delivery treatment burden patient demographics hospital & health care pharmaceuticals medical health care health wellness & fitness environmental services renewables & environment

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans